Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1986 Jul;30(1):25–30. doi: 10.1128/aac.30.1.25

In vitro activity of piperacillin, ticarcillin, and mezlocillin alone and in combination with aminoglycosides against Pseudomonas aeruginosa.

M D Lyon, K R Smith, M S Saag, G A Cloud, C G Cobbs
PMCID: PMC176428  PMID: 3092731

Abstract

A total of 103 isolates of Pseudomonas aeruginosa were studied to compare the in vitro effectiveness of three beta-lactam antibiotics (piperacillin, ticarcillin, and mezlocillin) when used alone and in combination with four aminoglycosides (tobramycin, gentamicin, amikacin, and netilmicin). All drugs were tested as single agents against a standard inoculum (5 X 10(5) CFU/ml). The three antipseudomonal penicillins were also tested against the isolates at a higher inoculum concentration (10(7) CFU/ml). Synergy testing was performed by the two-dimensional checkerboard method and was defined by a fractional bactericidal index of less than or equal to 0.5 and bacterial killing accomplished at antibiotic concentrations no greater than those achievable in serum. All combinations were assessed for synergy. The degree of synergy was further analyzed by dividing the isolates into groups based on their susceptibility and resistance to the individual agents in the combination. The overall effectiveness of the various aminoglycoside-antipseudomonal penicillin combinations was assessed regarding their ability to kill the isolates either as single agents or through synergy. Piperacillin was the most active antipseudomonal penicillin, and tobramycin and amikacin were the most active aminoglycosides when used as single agents. When tested against isolates at a higher inoculum concentration, ticarcillin was significantly more active than the other beta-lactams. The highest degree of overall synergy was noted with gentamicin-ticarcillin (78.2% of strains) and amikacin-piperacillin (77% of strains). When assessed for overall effectiveness, all combinations containing amikacin were the most active. The combination of amikacin-piperacillin was the most effective, with activity against 96% of all isolates.

Full text

PDF
25

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson E. T., Young L. S., Hewitt W. L. Antimicrobial synergism in the therapy of gram-negative rod bacteremia. Chemotherapy. 1978;24(1):45–54. doi: 10.1159/000237759. [DOI] [PubMed] [Google Scholar]
  2. Aronoff S. C., Klinger J. D. In vitro activities of aztreonam, piperacillin, and ticarcillin combined with amikacin against amikacin-resistant Pseudomonas aeruginosa and P. cepacia isolates from children with cystic fibrosis. Antimicrob Agents Chemother. 1984 Feb;25(2):279–280. doi: 10.1128/aac.25.2.279. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Barry A. L., Thornsberry C., Jones R. N., Gavan T. L. In vitro activity of mezlocillin and azlocillin compared with that of four other penicillins and two aminoglycosides. Cleve Clin Q. 1980 Winter;47(4):311–319. doi: 10.3949/ccjm.47.4.311. [DOI] [PubMed] [Google Scholar]
  4. Berenbaum M. C. A method for testing for synergy with any number of agents. J Infect Dis. 1978 Feb;137(2):122–130. doi: 10.1093/infdis/137.2.122. [DOI] [PubMed] [Google Scholar]
  5. Blair D. C., Duggan D. O., Schroeder E. T. Inactivation of amikacin and gentamicin by carbenicillin in patients with end-stage renal failure. Antimicrob Agents Chemother. 1982 Sep;22(3):376–379. doi: 10.1128/aac.22.3.376. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Corrado M. L., Landesman S. H., Cherubin C. E. Influence of inoculum size on activity of cefoperazone, cefotaxime, moxalactam, piperacillin, and N-formimidoyl thienamycin (MK0787) against Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1980 Dec;18(6):893–896. doi: 10.1128/aac.18.6.893. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Eng R. H., Smith S. M., Cherubin C. Inoculum effect of new beta-lactam antibiotics on Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1984 Jul;26(1):42–47. doi: 10.1128/aac.26.1.42. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Fu K. P., Neu H. C. Piperacillin, a new penicillin active against many bacteria resistant to other penicillins. Antimicrob Agents Chemother. 1978 Mar;13(3):358–367. doi: 10.1128/aac.13.3.358. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Glew R. H., Pavuk R. A. Early synergistic interaction between semisynthetic penicillins and aminoglycosidic aminocyclitols against Enterobacteriaceae. Antimicrob Agents Chemother. 1983 Jun;23(6):902–906. doi: 10.1128/aac.23.6.902. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Glew R. H., Pavuk R. A. Early synergistic interactions between amikacin and six beta-lactam antibiotics against multiply resistant members of the family Enterobacteriaceae. Antimicrob Agents Chemother. 1984 Sep;26(3):378–381. doi: 10.1128/aac.26.3.378. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Glew R. H., Pavuk R. A. Stability of gentamicin, tobramycin, and amikacin in combination with four beta-lactam antibiotics. Antimicrob Agents Chemother. 1983 Oct;24(4):474–477. doi: 10.1128/aac.24.4.474. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Hallander H. O., Dornbusch K., Gezelius L., Jacobson K., Karlsson I. Synergism between aminoglycosides and cephalosporins with antipseudomonal activity: interaction index and killing curve method. Antimicrob Agents Chemother. 1982 Nov;22(5):743–752. doi: 10.1128/aac.22.5.743. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Hooton T. M., Blair A. D., Turck M., Counts G. W. Synergism at clinically attainable concentrations of aminoglycoside and beta-lactam antibiotics. Antimicrob Agents Chemother. 1984 Oct;26(4):535–538. doi: 10.1128/aac.26.4.535. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Jones R. N., Packer R. R. Antimicrobial activity of amikacin combinations against Enterobacteriaceae moderately susceptible to third-generation cephalosporins. Antimicrob Agents Chemother. 1982 Dec;22(6):985–989. doi: 10.1128/aac.22.6.985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Jones R. N., Thornsberry C., Barry A. L., Fuchs P. C., Gavan T. L., Gerlach E. H. Piperacillin (T-1220), a new semisynthetic penicillin: in vitro antimicrobial activity comparison with carbenicillin, ticarcillin, ampicillin, cephalothin, cefamandole and cefoxitin. J Antibiot (Tokyo) 1977 Dec;30(12):1107–1114. doi: 10.7164/antibiotics.30.1107. [DOI] [PubMed] [Google Scholar]
  16. Kurtz T. O., Winston D. J., Bruckner D. A., Martin W. J. Comparative in vitro synergistic activity of new beta-lactam antimicrobial agents and amikacin against Pseudomonas aeruginosa and Serratia marcescens. Antimicrob Agents Chemother. 1981 Aug;20(2):239–243. doi: 10.1128/aac.20.2.239. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Mintz L., Drew W. L. Comparative synergistic activity of cefoperazone, cefotaxime, moxalactam, and carbenicillin, combined with tobramycin, against Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1981 Feb;19(2):332–334. doi: 10.1128/aac.19.2.332. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Pearson R. D., Steigbigel R. T., Davis H. T., Chapman S. W. Method of reliable determination of minimal lethal antibiotic concentrations. Antimicrob Agents Chemother. 1980 Nov;18(5):699–708. doi: 10.1128/aac.18.5.699. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Pickering L. K., Rutherford I. Effect of concentration and time upon inactivation of tobramycin, gentamicin, netilmicin and amikacin by azlocillin, carbenicillin, mecillinam, mezlocillin and piperacillin. J Pharmacol Exp Ther. 1981 May;217(2):345–349. [PubMed] [Google Scholar]
  20. Robinson R. G., Saunders J., Cassel R., Block C. S., Koornhof H. J. Comparative in vitro appraisal of piperacillin, including its activity against Salmonella typhi. Antimicrob Agents Chemother. 1980 Oct;18(4):493–501. doi: 10.1128/aac.18.4.493. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Shanholtzer C. J., Peterson L. R., Mohn M. L., Moody J. A., Gerding D. N. MBCs for Staphylococcus aureus as determined by macrodilution and microdilution techniques. Antimicrob Agents Chemother. 1984 Aug;26(2):214–219. doi: 10.1128/aac.26.2.214. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Thompson M. I., Russo M. E., Matsen J. M., Atkin-Thor E. Piperacillin pharmacokinetics in subjects with chronic renal failure. Antimicrob Agents Chemother. 1981 Mar;19(3):450–453. doi: 10.1128/aac.19.3.450. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Thompson M. I., Russo M. E., Saxon B. J., Atkin-Thor E., Matsen J. M. Gentamicin inactivation by piperacillin or carbenicillin in patients with end-stage renal disease. Antimicrob Agents Chemother. 1982 Feb;21(2):268–273. doi: 10.1128/aac.21.2.268. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. White G. W., Malow J. B., Zimelis V. M., Pahlavanzadeh H., Panwalker A. P., Jackson G. G. Comparative in vitro activity of azlocillin, ampicillin, mezlocillin, piperacillin, and ticarcillin, alone and in combination with an aminoglycoside. Antimicrob Agents Chemother. 1979 Apr;15(4):540–543. doi: 10.1128/aac.15.4.540. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES